NuGen Medical Devices Inc

Chart & Performance

D1W1MN

P/E

—

P/S

54.30

EPS

—

Div Yield, %

0.00%

Shrs. gr., 5y

53.54%

Rev. gr., 5y

Revenues

331k

+117.52%

Net income

-9m

L+67.84%

CFO

-7m

L+215.07%

Earnings

May 28, 2025

Profile

NuGen Medical Devices Inc., a specialty medical device company, focuses on developing and commercializing novel drug delivery technologies. It offers needle-free injection devices and systems for the administration of subcutaneous medication for various fields, including anaphylaxis, diabetes, severe migraine, erectile dysfunction, chronic anemia, neutropenia, autoimmune rheumatoid arthritis, growth and fertility hormone, and psoriasis, as well as DNA and conventional/pediatric vaccines. The company was formerly known as BuzBuz Capital Corp. NuGen Medical Devices Inc. is based in Toronto, Canada.

URL

https://www.nugenmd.com/

IPO date

May 28, 2019

Employees

Domiciled in

Incorporated in

Valuation

Order:

Title CAD in thousands, except ratios and share amounts	FY	FY	FY	FY	FY	FY	FY
Title CAD in thousands, except ratios and share amounts	2023‑12	2022‑12	2021‑12	2020‑12	2019‑12	2018‑12	2017‑12
Income
Revenues	331 117.52%	152 10.69%
Cost of revenue	7,689	4,946
Unusual Expense (Income)
NOPBT	(7,357)	(4,794)
NOPBT Margin
Operating Taxes	34	3
Tax Rate
NOPAT	(7,391)	(4,797)
Net income	(9,362) 67.84%	(5,578) -21.52%
Dividends
Dividend yield
Proceeds from repurchase of equity	6,580	673
BB yield
Debt
Debt current	2,169	200
Long-term debt	5,743	7,207
Deferred revenue
Other long-term liabilities		219
Net debt	7,447	7,275
Cash flow
Cash from operating activities	(6,714)	(2,131)
CAPEX	(3)
Cash from investing activities	(53)
Cash from financing activities	7,101	514
FCF	(8,222)	(3,979)
Balance
Cash	464	131
Long term investments
Excess cash	448	124
Stockholders' equity	(2,060)	(2,262)
Invested Capital	7,884	7,582
ROIC
ROCE
EV
Common stock shares outstanding	167,665	90,102
Price
Market cap
EV
EBITDA	(6,666)	(4,142)
EV/EBITDA
Interest	1,236	1,011
Interest/NOPBT